Sapient Capital’s Cardinal Health CAH Stock Holding History

Sapient Capital’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2,529	Closed	-$534K	–	410
2026 Q1	$534K	Buy	+2,529	New	+$545K	0.01%	266

Other funds holding CAH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Sapient Capital's CAH Position: Q2 2026 in Review

Sapient Capital sold out of Cardinal Health (CAH) in Q2 2026, closing a stake of 2,529 shares — an estimated $534K sold.

Sapient Capital first reported a position in CAH in Q1 2026 and held it in 1 quarter. The position peaked at $534K in Q1 2026. 1,490 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

Sapient Capital reported no remaining Cardinal Health position as of Q2 2026 after selling out during the quarter.
Sapient Capital sold 2,529 Cardinal Health shares in Q2 2026, an estimated $534K.
Sapient Capital first reported a position in Cardinal Health in Q1 2026 and held it in 1 quarter.
Sapient Capital's Cardinal Health position peaked at $534K in Q1 2026.
1,490 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Sapient Capital's 13F filing for Q2 2026, filed 9 Jul 2026.